genetic familial mutations
501 articles
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
Lucky to Find It Early
When Jeneen Genna did not feel well her doctor searched until they found pancreatic cancer. The BRCA2 mutation has her in a clinical trial.
Learn the Risk Factors
In the first Let’s Learn webinar, Learn the Risk Factors, experts explain how diabetes, genetic mutations, and pancreatitis impact pancreatic cancer.
Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment
A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.
A Family Tree Bent but Not Broken by Pancreatic Cancer
When Kay Zedd Kesser looks around her family tree, she sees pancreatic cancer everywhere. But screening saved Kay’s life.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
Leaning into the Fight: My Battle with Pancreatic Cancer
Despite an extensive family history of pancreatic cancer, Deanna Burney’s doctors did not keep a close eye on her pancreatic cyst.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day One
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Early Detection Makes All the Difference
Carolynn Kiel lost her mother and sister to pancreatic cancer. Regular screening allowed early detection of her pancreatic cancer.
Comprehensive Molecular Test Helps Classify Pancreatic Cysts
Dr. Aatur Singhi and colleagues are developing a test to help determine whether pancreatic cysts are likely to turn cancerous.
A New Drug Combination to Control Advanced Pancreatic Cancer
A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Symptoms and Risk Factors
Moderator Daniel G Garza leads Dr. Rachna Shroff and Dr. Fiyinfolu Balogun in a discussion of risk factors and symptoms of pancreatic cancer.
Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint
Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.